MetLife (MET) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
14 Nov, 2026Executive summary
Record adjusted EPS excluding notable items was $2.85, up 22% YoY; adjusted earnings on that basis rose 17% to $1.826B.
Adjusted ROE excluding notable items was 19.6%, above the 15%-17% annual target range.
Financial highlights
Net income available to common shareholders was $2.35B, versus $818M in 3Q25; diluted EPS was $3.67, versus $1.22.
Adjusted earnings were $1.780B, or $2.78 per share; excluding $46M of notable items, they were $1.826B, or $2.85 per share.
Premiums, fees and other revenues were $14.056B; adjusted premiums, fees and other revenues were $13.919B.
Pre-tax variable investment income was $720M, above the $400M quarterly target; adjusted net investment income rose 10% to $6.0B.
Outlook and guidance
RIS FY adjusted earnings were expected slightly above the midpoint of the $1.6B-$1.8B range, assuming normal Q4 variable investment income.
MIM remained on track for FY adjusted earnings of $240M-$280M; FY variable investment income was expected to exceed the ~$1.6B guide.
Full-year direct expense ratio was expected below the 12.1% target; the 2029 target remained 11.3%.
Free cash flow ratio outlook remained 65%-75%; management expected to meet full-year cash flow and expense ratio targets.
RIS Q4 core spread was expected within 95-100 bps; total spread outlook was 100-120 bps assuming normal variable investment income.
Latest events from MetLife
- Ahead-of-plan growth combines rising returns, expanding businesses and disciplined capital deployment.MET
J.P. Morgan European Financials Conference - Strategy execution is ahead of targets, with strong growth, disciplined costs, and global momentum.MET
KBW Insurance Conference 2026 - 20% adjusted EPS growth in 2Q26 reflects strong global execution and disciplined capital management.MET
Investor presentation - Achieved 20% adjusted EPS growth, driven by global diversification and disciplined capital management.MET
Investor presentation - Adjusted earnings up 15% to $1.6B, ROE at 17%, with broad segment growth and strong capital returns.MET
Q2 2026 - Exceeded strategic targets and set a new growth-focused agenda with strong global momentum.MET
2024 KBW Insurance Conference - New Frontier strategy targets double-digit EPS growth and 15–17% ROE through scale, innovation, and global expansion.MET
Investor Day 2024 - Net income and adjusted earnings surged, driven by Group Benefits and strong capital returns.MET
Q2 2024 - New Frontier strategy targets responsible growth, higher ROE, and global expansion.MET
Bank of America Securities Financial Services Conference